ChiCTR2600119873 版本V1.0 版本创建时间2026/03/04 17:19:44 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2600119873 

最近更新日期:

Date of Last Refreshed on:

2026-03-04 17:19:28 

注册时间:

Date of Registration:

2026-03-04 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

辩证行为疗法导向精准化心理数字干预

Public title:

Dialectical Behavior Therapy-Guided Precision Psychological Digital Intervention Program

注册题目简写:

English Acronym:

研究课题的正式科学名称:

安宁疗护一线医护人员的职业耗竭赋能:辩证行为疗法导向精准化心理数字干预方案的构建与应用

Scientific title:

Empowerment for Burnout in Frontline Hospice and Palliative Care Staff: Development and Application of a Dialectical Behavior Therapy-Guided Precision Psychological Digital Intervention Program

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

杨舒岚 

研究负责人:

杨舒岚 

Applicant:

Shulan Yang 

Study leader:

Shulan Yang 

申请注册联系人电话:

Applicant telephone:

+86 571 8798 7373

研究负责人电话:

Study leader's
telephone:

+86 571 8798 7373

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

947373396@qq.com

研究负责人电子邮件:

Study leader's E-mail:

947373396@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

浙江省杭州市西湖区灵隐路12号

研究负责人通讯地址:

浙江省杭州市西湖区灵隐路12号

Applicant address:

No. 12 Lingyin Road, Xihu District, Hangzhou City, Zhejiang Province

Study leader's address:

No. 12 Lingyin Road, Xihu District, Hangzhou City, Zhejiang Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

浙江医院

Applicant's institution:

Zhejaing Hospital

研究负责人所在单位:

浙江医院

Affiliation of the Leader:

Zhejaing Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

ZJHIRB-2025-173K

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

浙江医院伦理审查委员会

Name of the ethic committee:

Ethics Review Committee of Zhejiang Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-09-19 00:00:00

伦理委员会联系人:

谢小萍

Contact Name of the ethic committee:

Xie Xiaoping

伦理委员会联系地址:

浙江省杭州市西湖区灵隐路12号

Contact Address of the ethic committee:

No. 12 Lingyin Road, Xihu District, Hangzhou City, Zhejiang Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 571 81595231

伦理委员会联系人邮箱:

Contact email of the ethic committee:

920628092@qq.com

研究实施负责(组长)单位:

浙江医院

Primary sponsor:

Zhejaing Hospital

研究实施负责(组长)单位地址:

浙江省杭州市西湖区灵隐路12号

Primary sponsor's address:

No. 12 Lingyin Road, Xihu District, Hangzhou City, Zhejiang Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

浙江省

市(区县):

Country:

China

Province:

Zhejiang

City:

单位(医院):

浙江医院

具体地址:

浙江省杭州市西湖区灵隐路12号

Institution
hospital:

Zhejaing Hospital

Address:

No. 12 Lingyin Road, Xihu District, Hangzhou City, Zhejiang Province

经费或物资来源:

2025年度浙江省卫生健康行业科技计划

Source(s) of funding:

2025 Medical and Health Science Program of Zhejiang Province

研究疾病:

职业耗竭  

Target disease:

Burnout

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

1. 系统剖析安宁疗护一线医护人员职业耗竭特征,识别与职业耗竭显著关联的关键影响因素,并挖掘其心理困境; 2. 在DBT指导下构建针对安宁疗护一线医护人员的的精准化心理数字干预方案; 3. 应用3.2.2构建的方案并验证可行性、有效性,明确干预方案对结局指标的影响。  

Objectives of Study:

1. Systematically analyze the characteristics of occupational burnout among frontline medical and nursing staff in hospice and palliative care, identify key influencing factors significantly associated with occupational burnout, and explore their psychological dilemmas. 2. Develop a precision-based psychological digital intervention program for frontline medical and nursing staff in hospice and palliative care under the guidance of Dialectical Behavior Therapy (DBT). 3. Apply the program developed in 3.2.2, verify its feasibility and effectiveness, and clarify the impact of the intervention program on outcome indicators.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.设置安宁疗护病床的综合医院临床岗位全职医护工作者; 2.每周平均工作时数≥36小时,直接参与终末期患者照护; 3.自愿签署书面知情同意书,承诺全程参与研究; 4.通过职业倦怠评估工具(BAT量表)筛选为职业耗竭高风险人群(BAT总分≥50分)或中文版知觉压力量表(CPSS)评分≥20分; 5.无计划在12个月内离职或转岗,确保研究连续性。

Inclusion criteria

1. Full-time medical and nursing staff in clinical positions at general hospitals with hospice and palliative care beds.? 2. Those with an average weekly working hours of >= 36 hours and directly involved in the provision of care for terminally ill patients.? 3. Those who voluntarily sign the written informed consent form and commit to participating in the study in full.? 4. Those screened as a high-risk group for occupational burnout via the occupational burnout assessment tool (BAT Scale) (with a total BAT score >= 50 points) or those with a score of >= 20 points on the Chinese Version of the Perceived Stress Scale (CPSS).? 5. Those who have no plans to resign or transfer to another position within 12 months to ensure the continuity of the study.

排除标准:

1.过去4周内接受过系统性心理治疗(如认知行为疗法、正念训练)或正在服用精神类药物(如抗抑郁药、抗焦虑药); 2.近6个月内参与过其他心理干预研究项目; 3.近3个月内经历重大创伤事件者; 4.存在严重躯体疾病或精神障碍者; 5.进修、实习或未完成岗位定级的医护人员。

Exclusion criteria:

1.Those who have received systematic psychotherapy (e.g., Cognitive Behavioral Therapy [CBT], mindfulness training) within the past 4 weeks or are currently taking psychotropic medications (e.g., antidepressants, anxiolytics).? 2. Those who have participated in other psychological intervention research projects within the past 6 months.? 3. Those who have experienced major traumatic events within the past 3 months.? 4. Those with severe physical illnesses or mental disorders.? 5. Medical and nursing staff who are in further study, on internship, or have not completed job grading.

研究实施时间:

Study execute time:

From 2026-01-01 00:00:00 To 2028-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-06-01 00:00:00 To 2027-12-31 00:00:00

干预措施:

Interventions:

组别:

DBT干预组

样本量:

71

Group:

DBT Group

Sample size:

干预措施:

DBT数字化干预

干预措施代码:

Intervention:

DBT Digital Intervention

Intervention code:

组别:

等待列表对照组

样本量:

71

Group:

Wait-list Control Group

Sample size:

干预措施:

暂时不接受干预,在实验组完成干预后接受相同干预

干预措施代码:

Intervention:

Not accepting intervention temporarily, receiving the same intervention after the experimental group completes the intervention

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

浙江省 

市(区县):

 

Country:

China

Province:

Zhejiang

City:

单位(医院):

浙江医院 

单位级别:

三级甲等 

Institution
hospital:

zhejiang hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

浙江省 

市(区县):

 

Country:

China

Province:

Zhejiang

City:

单位(医院):

浙江省安宁疗护指导中心 

单位级别:

三级甲等 

Institution
hospital:

Zhejiang Provincial Hospice and Palliative Care Guidance Center

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

职业耗竭程度

指标类型:

主要指标

Outcome:

Level of burnout

Type:

Primary indicator

测量时间点:

计划分4次进行评价,分别为第零周(W0)、第十二周(W12)、第二十四周(W24)及第三十六周(W36)

测量方法:

通过BAT量表(自评量表)评估职业耗竭变化。

Measure time point of outcome:

Evaluations are planned to be conducted in 4 rounds, namely at Week 0, Week 12, Week 24 and Week 36.

Measure method:

Assess changes in burnout via the BAT Scale (self-reported scale).

指标中文名:

压力感知

指标类型:

次要指标

Outcome:

Perceived Stress

Type:

Secondary indicator

测量时间点:

计划分4次进行评价,分别为第零周(W0)、第十二周(W12)、第二十四周(W24)及第三十六周(W36)

测量方法:

通过中文版知觉压力量表(CPSS)评估压力感知。

Measure time point of outcome:

Evaluations are planned to be conducted in 4 rounds, namely at Week 0, Week 12, Week 24 and Week 36.

Measure method:

Assess changes in perceived stress via the Chinese Perceived Stress Scales,CPSS.

指标中文名:

心理健康状况

指标类型:

次要指标

Outcome:

General status in mental health

Type:

Secondary indicator

测量时间点:

计划分4次进行评价,分别为第零周(W0)、第十二周(W12)、第二十四周(W24)及第三十六周(W36)

测量方法:

通过12项一般健康问卷(GHQ-12)评估心理健康状况。

Measure time point of outcome:

Evaluations are planned to be conducted in 4 rounds, namely at Week 0, Week 12, Week 24 and Week 36.

Measure method:

Assess changes in mental health status via the GHQ-12.

指标中文名:

心理弹性

指标类型:

次要指标

Outcome:

Resilience

Type:

Secondary indicator

测量时间点:

计划分4次进行评价,分别为第零周(W0)、第十二周(W12)、第二十四周(W24)及第三十六周(W36)

测量方法:

通过简易心理弹性量表(CD-RISC-10)评估心理弹性。

Measure time point of outcome:

Evaluations are planned to be conducted in 4 rounds, namely at Week 0, Week 12, Week 24 and Week 36.

Measure method:

Assess changes in resilience via the CD-RISC-10.

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

NA

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 25 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由专业统计人员使用统计软件生成随机数列。

Randomization Procedure (please state who generates the random number sequence and by what method):

Eligible medical and nursing staff are randomly allocated in a 1:1 ratio via simple randomization. The random sequence is generated by a statistician using statistical software.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

单盲,对评估者设盲

Blinding:

Single blind study with blinded-evaluators

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不公开原始数据。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

UA

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用标准化多中心数据采集流程: 工具:各中心使用统一的电子数据采集系统; 内容:采集基线资料(人口学特征、职业信息等)、干预过程数据(干预执行情况、依从性等)、结局指标数据(职业耗竭量表得分及其他评估结果等); 管理:设置分级访问权限,定期开展数据核查(逻辑校验、一致性检查);原始数据经加密后备份存储,确保完整性、准确性与安全性。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data collection and management follow a standardized multicenter procedure: Tool: A unified electronic data capture system is used across all centers; Content: Baseline information (demographic characteristics, occupational details, etc.), intervention process data (implementation of the intervention, adherence, etc.), and outcome indicator data (BAT scales and other assessment results, etc.) are collected; Management: Hierarchical access permissions are set; regular data verification (logical validation, consistency checks) is conducted; raw data are encrypted and backed up to ensure integrity, accuracy, and security.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-03-04 17:19:28